Engineering Licensing Protein Production 
Drug Target Review
APRIL 5, 2024
However, there is significant variability within the various CHO cell lines, and CDMOs often have differing levels of success in optimising their cells for protein production. They’re prepared for complexity Successful expression of the gene of interest is not sufficient on its own for large-scale production.
The Pharma Data
JULY 3, 2025
For years, the company was primarily known for licensing its C1 platform for the development of therapeutic biologics and vaccines. However, Dyadic has now sharpened its strategic focus on commercializing non-therapeutic proteins—input molecules that are crucial for downstream manufacturing and production processes in various industries. “We
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Codon
AUGUST 10, 2023
Credit: Bruce Wetzel and Harry Schaefer, NCI, NIH | License Progress in biology is arguably moving faster today than at any point in the course of human history. Engineered biology has profound potential to change how we live, but the field has become broad, bloated, nebulous. → means “start here.” Nature (2005).
Codon
MAY 29, 2025
The way we typically prepare white beans completely deactivates the mild toxin that could otherwise cause food poisoning, the highly venomous cone snail that produced that shell was long gone by the time you picked it up, and Botox has been safe to inject by licensed healthcare professionals since FDA approval in 1991.
Codon
AUGUST 10, 2023
Credit: Bruce Wetzel and Harry Schaefer, NCI, NIH | License Last edit: 13 September 2023 Progress in biology is arguably moving faster today than at any point in the course of human history. Engineered biology has profound potential to change how we live, but the field has become broad, bloated, nebulous. Nature (2005). Nature (2016).
Expert insights. Personalized for you.
96 
Let's personalize your content